Xigen
Epalinges · Founded 2002
About Xigen
Xigen, a biopharmaceutical company, develops therapeutics to inhibit intracellular protein interactions.
Company Facts
- Founded: 2002
- Legal name: Xigen SA
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $41.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Nov 2009)
- Website: xigenpharma.com
- Phone: 41213211081
Social Profiles
Canonical: https://fsome.com/organization/xigen-8388751 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.